CinCor Pharma, Inc.
CINC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,978 | -$21,075 | -$16,697 | -$29,343 |
| Dep. & Amort. | $4 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,303 | $1,241 | $1,224 | $749 |
| Change in WC | $4,810 | $421 | -$5,247 | $3,931 |
| Other Non-Cash | -$254 | -$140 | $3,007 | $13,638 |
| Operating Cash Flow | -$15,114 | -$19,554 | -$17,713 | -$11,026 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$63 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$108,165 | -$67,386 | -$159,839 | $0 |
| Inv. Sales/Matur. | $45,000 | $50,000 | $10,000 | $0 |
| Other Inv. Act. | $0 | -$42 | $0 | $0 |
| Investing Cash Flow | -$63,228 | -$17,429 | -$149,839 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $243,225 | $0 | $197,767 | $142,865 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $243,280 | -$0 | $195,548 | $5,923 |
| Financing Cash Flow | $243,280 | -$0 | $195,548 | $5,923 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $164,937 | -$36,982 | $27,996 | -$5,103 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $127,620 | $164,602 | $136,606 | $141,708 |
| End Cash | $292,557 | $127,620 | $164,602 | $136,606 |
| Free Cash Flow | -$15,178 | -$19,554 | -$17,713 | -$11,026 |